Your browser doesn't support javascript.
loading
Extensive metabolism and route-dependent pharmacokinetics of bisphenol A (BPA) in neonatal mice following oral or subcutaneous administration.
Draganov, Dragomir I; Markham, Dan A; Beyer, Dieter; Waechter, John M; Dimond, Stephen S; Budinsky, Robert A; Shiotsuka, Ronald N; Snyder, Stephanie A; Ehman, Kimberly D; Hentges, Steven G.
  • Draganov DI; WIL Research, Ashland, OH 44805, USA. Electronic address: dragomir_ivanov.draganov@roche.com.
  • Markham DA; The Dow Chemical Co., Midland, MI 48674, USA. Electronic address: DAMarkam@dow.com.
  • Beyer D; Bayer Healthcare AG, Wuppertal D-42096, Germany. Electronic address: dieter.beyer@bayer.com.
  • Waechter JM; The Dow Chemical Co., Midland, MI 48674, USA. Electronic address: john.waechter@cardno.com.
  • Dimond SS; SABIC Innovative Plastics, Pittsfield, MA 01201, USA. Electronic address: Stephen.Dimond@sabic-ip.com.
  • Budinsky RA; The Dow Chemical Co., Midland, MI 48674, USA. Electronic address: RABudinsky@dow.com.
  • Shiotsuka RN; Bayer Material Science, Pittsburgh, PA 15205, USA.
  • Snyder SA; Bayer Material Science, Pittsburgh, PA 15205, USA. Electronic address: stephanie.snyder@bayer.com.
  • Ehman KD; Toxicology Regulatory Services, Inc., Charlottesville, VA 22911, USA. Electronic address: kehman@rti.org.
  • Hentges SG; American Chemistry Council, Washington, D.C. 20002, USA. Electronic address: Steve_Hentges@americanchemistry.com.
Toxicology ; 333: 168-178, 2015 Jul 03.
Article en En | MEDLINE | ID: mdl-25929835
ABSTRACT
Orally administered bisphenol A (BPA) undergoes efficient first-pass metabolism to produce the inactive conjugates BPA-glucuronide (BPA-G) and BPA-sulfate (BPA-S). This study was conducted to evaluate the pharmacokinetics of BPA, BPA-G and BPA-S in neonatal mice following the administration of a single oral or subcutaneous (SC) dose. This study consisted of 3 phases (1) mass-balance phase in which effective dose delivery procedures for oral or SC administration of (3)H-BPA to postnatal day three (PND3) mice were developed; (2) pharmacokinetic phase during which systemic exposure to total (3)H-BPA-derived radioactivity in female PND3 mice was established; and (3) metabolite profiling phase in which 50 female PND3 pups received either a single oral or SC dose of (3)H-BPA. Blood was collected from 5 pups/route/time-point at various times post-dosing, the blood plasma samples were pooled by group, and time-point and samples were profiled by HPLC with fraction collection. Fractions were analyzed for total radioactivity and data used to reconstruct radiochromatograms and to integrate individual peaks. The identity of the BPA, BPA-G, and BPA-S peaks was confirmed using authentic standards and LC-MS/MS analysis. The result of this study revealed that female PND3 mice have the capacity to metabolize BPA to BPA-G, BPA-S and other metabolites after both routes of administration. Systemic exposure to free BPA is route-dependent as the plasma concentrations were lower following oral administration compared to SC injection.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fenoles / Compuestos de Bencidrilo Límite: Animals Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fenoles / Compuestos de Bencidrilo Límite: Animals Idioma: En Año: 2015 Tipo del documento: Article